Hemorrhagic disease

Part of

Sub-types of Hemorrhagic disease

• Hemophilia A 180 trials
  5 sub-types

  • Severe hemophilia A 50 trials
  • Moderately severe hemophilia A 4 trials
  • Mild hemophilia A 2 trials
  • Hemophilia A with vascular abnormality 0 trials
  • Symptomatic form of hemophilia A in female carriers 0 trials
• Purpura 4 trials · 117 incl. sub-types
  3 sub-types

  • Thrombocytopenic purpura 8 trials · 116 incl. sub-types Sub-types →
  • Hyperglobulinemic purpura 0 trials
  • Purpura fulminans 0 trials Sub-types →
• Hemophilia B 84 trials · 91 incl. sub-types
  4 sub-types

  • Severe hemophilia B 9 trials
  • Moderately severe hemophilia B 2 trials
  • Mild hemophilia B 1 trial
  • Symptomatic form of hemophilia B in female carriers 0 trials
• Vascular hemostatic disease 62 trials · 63 incl. sub-types
  2 sub-types

  • Cavernous hemangioma 1 trial Sub-types →
  • Shwartzman phenomenon 0 trials
• Hereditary von Willebrand disease 18 trials · 29 incl. sub-types
  5 sub-types

  • Von Willebrand disease 3 9 trials
  • Von Willebrand disease 2 4 trials · 5 incl. sub-types Sub-types →
  • Von Willebrand disease 1 3 trials
  • Von Willebrand disease, X-linked form 0 trials
  • Platelet-type von Willebrand disease 0 trials
• Inherited bleeding disorder, platelet-type 6 trials · 26 incl. sub-types
  28 sub-types

  • Glanzmann thrombasthenia 8 trials Sub-types →
  • Platelet-type bleeding disorder 10 8 trials
  • Congenital thrombotic thrombocytopenic purpura 5 trials
  • Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss 1 trial
  • Bernard-Soulier syndrome 0 trials Sub-types →
  • Ehlers-Danlos syndrome, fibronectinemic type 0 trials
  • Quebec platelet disorder 0 trials
  • Scott syndrome 0 trials
  • Bleeding diathesis due to thromboxane synthesis deficiency 0 trials
  • Bleeding disorder, platelet-type, 21 0 trials
  • Bleeding disorder, platelet-type, 22 0 trials
  • Bleeding disorder, platelet-type, 24 0 trials
  • Bleeding disorder, platelet-type, 25 0 trials
  • Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder 0 trials
  • Gray platelet syndrome 0 trials
  • Platelet-type bleeding disorder 11 0 trials
  • Platelet-type bleeding disorder 12 0 trials
  • Platelet-type bleeding disorder 14 0 trials
  • Platelet-type bleeding disorder 15 0 trials
  • Platelet-type bleeding disorder 16 0 trials
  • Platelet-type bleeding disorder 17 0 trials
  • Platelet-type bleeding disorder 18 0 trials
  • Platelet-type bleeding disorder 19 0 trials
  • Platelet-type bleeding disorder 20 0 trials
  • Platelet-type bleeding disorder 8 0 trials
  • Platelet-type bleeding disorder 9 0 trials
  • Platelet-type von Willebrand disease 0 trials
  • Primary release disorder of platelets 0 trials
• Acquired hemophilia 2 trials · 8 incl. sub-types
  3 sub-types

  • Acquired hemophilia A 6 trials
  • Acquired factor XI deficiency 0 trials
  • Acquired hemophilia B 0 trials
• Factor VII deficiency 6 trials
  2 sub-types

  • Congenital factor VII deficiency 3 trials
  • Acquired factor VII deficiency 0 trials
• Congenital fibrinogen deficiency 2 trials · 6 incl. sub-types
  1 sub-type

  • Familial dysfibrinogenemia 2 trials · 6 incl. sub-types Sub-types →
• Fetal and neonatal alloimmune thrombocytopenia 4 trials
  3 sub-types

  • Fetomaternal alloimmune thrombocytopenia 1 0 trials
  • Fetomaternal alloimmune thrombocytopenia 2 0 trials
  • Fetomaternal alloimmune thrombocytopenia 3 0 trials
• Congenital vitamin K-dependent coagulation factors deficiency 0 trials · 4 incl. sub-types
  5 sub-types

  • Congenital factor VII deficiency 3 trials
  • Vitamin K-dependent clotting factors, combined deficiency of, type 1 1 trial
  • Congenital factor X deficiency 0 trials
  • Congenital prothrombin deficiency 0 trials
  • Vitamin K-dependent clotting factors, combined deficiency of, type 2 0 trials
• Acquired von willebrand syndrome 3 trials
• Factor X deficiency 2 trials
  2 sub-types

  • Acquired factor X deficiency 1 trial
  • Congenital factor X deficiency 0 trials
• Congenital factor XII deficiency 1 trial
• Congenital plasminogen activator inhibitor type 1 deficiency 1 trial
• East Texas bleeding disorder 0 trials
• Alpha-2-plasmin inhibitor deficiency 0 trials
• Combined deficiency of factor V and factor VIII 0 trials
  3 sub-types

  • Factor 5 and Factor VIII, combined deficiency of, 2 0 trials
  • Factor V and factor VIII, combined deficiency of, type 1 0 trials
  • Factor V and factor VIII, combined deficiency of, with normal protein C and protein C inhibitor 0 trials
• Congenital factor V deficiency 0 trials
• Congenital factor XI deficiency 0 trials
• Congenital factor XIII deficiency 0 trials
  2 sub-types

  • Factor XIII, A subunit, deficiency of 0 trials
  • Factor XIII, b subunit, deficiency of 0 trials
• Congenital high-molecular-weight kininogen deficiency 0 trials
• Hemophilia B leyden 0 trials
• Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation 0 trials
• Inherited prekallikrein deficiency 0 trials
• Multiple sclerosis-ichthyosis-factor VIII deficiency syndrome 0 trials
• Prothrombin deficiency 0 trials
  2 sub-types

  • Acquired prothrombin deficiency 0 trials
  • Congenital prothrombin deficiency 0 trials
• Thrombomodulin-related bleeding disorder 0 trials